The global healthcare industry experienced a 52% drop in company filings mentions of COVID-19 in Q2 2023 compared with the previous quarter, with the highest share accounted for by HCA Healthcare with 37% year-on-year decrease, according to GlobalData’s analysis of over 39 healthcare company filings. GlobalData’s COVID-19 Cross-Sector Impact – Thematic Research report helps understand how the effect of COVID-19 on Healthcare sector compares with 17 other key sectors, in terms of equity indices, M&A volumes, jobs index, and filings. Buy the report here.
Notably, COVID-19 was one of the most frequently referenced themes in Q2 2023, ranking highest in terms of mentions, ahead of mobile health and remote patient monitoring, according to GlobalData.
Of the top leading companies in the healthcare industry, HCA Healthcare had the greatest increase in references for COVID-19 in Q2 2023, compared with the previous quarter. GlobalData identified 26 COVID-19-related sentences in the company's filings - 6% of all sentences - and an increase of 100% in Q2 2023 compared with Q2 2022. IHH Healthcare’s mentions of COVID-19 rose by 100% to 4.
GlobalData’s Company Filings Analytics also applies sentiment weight to reference sentences, based on whether the sentences are positive, negative, or neutral. Starting at 100 in 2020, an index over 100 is more positive. The overall index for COVID-19 in Q2 2023 was 216.
To further understand GlobalData's analysis on COVID-19 Cross-Sector Impact - Thematic Research, buy the report here.